Treatise on Ocular Drug Delivery

Author(s): Ripal J. Gaudana, Megha Barot, Ashaben Patel, Varun Khurana and Ashim K. Mitra

DOI: 10.2174/9781608051755113010007

Barriers for Posterior Segment Ocular Drug Delivery

Pp: 68-95 (28)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Drug delivery for the treatment of posterior segment diseases has become a major challenge in the field of ophthalmology due to its restrictive barrier functionalities. Blood-ocular barriers act as a physical barrier between the local blood vessels, ocular tissues and fluids which restrict the passage of various solutes and fluids. Ocular barriers may be classified as static and dynamic barriers. Static barrier include sclera, Bruch’s membrane-choroid (BC), retinal pigment epithelium (RPE) and conjunctiva while dynamic barriers include drug clearance mechanism through blood and lymphatic vessels. Apart from above mentioned barriers, it is also imperative to understand the role of enzymes and transporters in drug disposition. Overall, it is essential to understand anatomy, physiology and disposition mechanisms of eye and interaction between drug molecules/formulation with various ocular tissues in order to design a successful drug delivery system.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books